The Journal of Organic Chemistry
Page 26 of 35
1
+29.8° (c 1.0, CHCl3). H NMR (400 MHz, CDCl3) δ 11.80 (d, J = 7.8 Hz, 1H), 8.12 – 8.03 (m, 2H), 7.59
(s, 1H), 7.54 – 7.48 (m, 3H), 7.47 – 7.41 (m, 3H), 7.39 – 7.33 (m, 2H), 7.11 (dm, J = 8.5 Hz, 2H), 6.72 (dm,
J = 8.5 Hz, 2H), 5.93 (br s, 1H), 5.17 (td, J = 7.7, 4.9 Hz, 1H), 3.82 (s, 3H), 3.31 (dd, J = 14.1, 4.9 Hz, 1H),
3.18 (dd, J = 14.1, 7.7 Hz, 1H), 2.58 (s, 3H). 13C{1H} NMR (101 MHz, CDCl3) δ 200.2, 175.4, 170.7, 164.6,
158.1, 157.7, 155.6, 155.1, 139.7, 136.9, 130.8, 130.7, 129.2, 128.4, 128.2, 128.0, 127.6, 126.8, 122.5,
115.9, 113.9, 100.3, 56.2, 53.1, 38.0, 32.5. HRMS (ESI/Q-TOF) m/z: [M + H]+ calcd for C32H27N2O6
535.1864, found 535.1864.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(S)-Methyl 2-(3-acetyl-4-oxo-5,7-diphenyl-4H-pyrano[2,3-b]pyridin-2-ylamino)-3-(1H-indol-3-
yl)propanoate (6al) was prepared from 4a according to procedure A (1 mL DCM, rt, 60 h) using L-
tryptophan methyl ester hydrochloride (38 mg, 0.15 mmol) and triethylamine (15 μL, 0.11 mmol), and was
20
eluted with DCM/EtOAc 9:1. 45 mg (0.081 mmol, 81% yield), pale yellow solid (MeOH).
−19.8° (c
[ ]
α
D
1.0, CHCl3). 1H NMR (400 MHz, CDCl3) δ 11.88 (d, J = 7.5 Hz, 1H), 8.20 (br s, 1H), 8.11 – 8.04 (m, 2H),
7.71 – 7.67 (m, 1H), 7.57 (s, 1H), 7.54 – 7.48 (m, 3H), 7.48 – 7.42 (m, 3H), 7.38 – 7.33 (m, 2H), 7.33 – 7.29
(m, 1H), 7.23 (br d, J = 2.4 Hz, 1H), 7.20 – 7.12 (m, 2H), 5.26 (td, J = 7.3, 5.2 Hz, 1H), 3.78 (s, 3H), 3.55
(dd, J = 14.8, 5.2 Hz, 1H), 3.49 (dd, J = 14.8, 7.2 Hz, 1H), 2.57 (s, 3H). 13C{1H} NMR (101 MHz, CDCl3) δ
199.8, 175.4, 171.1, 164.7, 157.9, 157.7, 155.0, 139.8, 136.9, 136.4, 130.7, 129.1, 128.3, 128.2, 128.0,
127.6, 127.1, 123.7, 122.5, 122.2, 119.9, 118.7, 113.9, 111.5, 109.4, 100.3, 55.3, 53.1, 32.6, 28.9. HRMS
(ESI/Q-TOF) m/z: [M + H]+ calcd for C34H28N3O5 558.2023, found 558.2017.
(S)-Methyl 2-(3-acetyl-4-oxo-5,7-diphenyl-4H-pyrano[2,3-b]pyridin-2-ylamino)-3-(1H-imidazol-
4-yl)propanoate (6am) was prepared from 4a according to procedure A (1 mL DCM, rt, 72 h) using L-
histidine methyl ester dihydrochloride (29 mg, 0.12 mmol) and triethylamine (28 μL, 0.2 mmol), and was
20
eluted with DCM/EtOH 93:7. 22 mg (0.043 mmol, 43% yield), yellowish solid (Et O).
−3.4° (c 0.5,
[ ]
α
2
D
CHCl3). 1H NMR (400 MHz, CDCl3) δ 11.85 (d, J = 7.6 Hz, 1H), 8.09 – 8.03 (m, 2H), 7.56 – 7.53 (m, 2H),
7.52 – 7.34 (m, 9H), 6.93 (s, 1H), 5.30 – 5.22 (m, 1H), 3.84 (s, 3H), 3.38 (dd, J = 15.0, 5.9 Hz, 1H), 3.30
13
(dd, J = 15.0, 4.9 Hz, 1H), 2.55 (s, 3H). C{1H} NMR (151 MHz, CDCl3) δ 199.8, 175.5, 170.7, 164.6,
158.1, 157.8, 155.1, 139.7, 136.8, 135.6, 130.8, 129.1, 128.4 (2C), 128.2 (2C), 128.0, 127.6, 122.4, 113.9,
100.4, 54.6, 53.2, 32.6, 30.5. HRMS (ESI/Q-TOF) m/z: [M + H]+ calcd for C29H25N4O5 509.1819, found
509.1825.
3-Acetyl-2-(benzylamino)-5-(4-chlorophenyl)-7-phenyl-4H-pyrano[2,3-b]pyridin-4-one
(6ba)
was prepared from 4b and benzylamine (12 μL, 0.11 mmol) according to procedure A (2 mL DCM, rt, 24
1
h), and was eluted with DCM/EtOAc 49:1. 47 mg (0.098 mmol, 98% yield), white solid (DCM). H NMR
(400 MHz, CDCl3) δ 11.93 (br t, J = 5.5 Hz, 1H), 8.14 – 8.07 (m, 2H), 7.57 (s, 1H), 7.55 – 7.49 (m, 3H),
7.48 – 7.38 (m, 6H), 7.37 – 7.30 (m, 3H), 4.91 (d, J = 5.8 Hz, 2H), 2.60 (s, 3H). 13C{1H} NMR (101 MHz,
CDCl3) δ 199.8, 175.3, 164.9, 158.3, 157.9, 153.8, 138.2, 136.8, 136.3, 134.5, 130.8, 129.6, 129.2 (2C),
ACS Paragon Plus Environment